国际英语新闻:Nuclear watchdog says DPRK is making progress with atomic plans
VIENNA, May 2 (Xinhua) -- The Democratic People's Republic of Korea is making progress with its nuclear program and its launching of missiles is extremely worrying, the International Atomic Energy Agency (IAEA) said on Tuesday.
"I remain seriously concerned about the nuclear programme of the Democratic People's Republic of Korea. Last year, it carried out two more nuclear tests. It continues to launch missiles and threaten other countries. This is extremely worrying," IAEA Director General Yukiya Amano told a conference.
The DPRK declared its withdrawal from The Treaty on the Non-Proliferation (NPT) of Nuclear Weapons in 2003. All IAEA nuclear inspectors have since left the country, making it difficult to monitor the DPRK's atomic program. The DPRK is no longer an IAEA member state.
"Without direct access to relevant sites and locations, the agency cannot confirm the operational status of North Korea's nuclear facilities. But all the indications suggest that North Korea is making progress with its nuclear program," the chief of the UN nuclear watchdog said.
He said that though it is difficult, his team was trying to collect information regarding the DPRK's nuclear program, urge the country to fully comply with relevant UN Security Council resolutions and cooperate with the agency in implementing its NPT Safeguards Agreement.
相关文章
- 欧美文化:Russian FM visits Algeria to mark 60th anniversary of ties
- 欧美文化:Spanish government sacks spy chief after phone tapping scandal
- 欧美文化:Moroccan, Egyptian FMs discuss prospects of bolstering cooperation
- 欧美文化:Macron visits Berlin on first foreign trip after re-election
- 欧美文化:Ukrainian president, Swedish PM discuss defense support for Ukraine over phone
- 欧美文化:Serbia, China commemorate journalists killed in NATO bombing 23 years ago
- 欧美文化:Two suspects arrested for killing 3 Israelis in stabbing attack
- 欧美文化:Israel celebrates 74th Independence Day
- 欧美文化:Putin, Bennett discuss Ukraine over phone
- 欧美文化:U.S. FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk